Cargando…
Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas
Glaucoma drainage devices are an option in refractory glaucomas for control of intraocular pressure (IOP). We evaluated the outcome of pars plana Ahmed glaucoma valve along with triamcinolone-assisted vitrectomy in 11 eyes with uncontrolled IOP on maximum tolerable antiglaucoma therapy. The mean pre...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992926/ https://www.ncbi.nlm.nih.gov/pubmed/20689206 http://dx.doi.org/10.4103/0301-4738.67068 |
_version_ | 1782192792065277952 |
---|---|
author | Dada, Tanuj Bhartiya, Shibal Vanathi, Murugesan Panda, Anita |
author_facet | Dada, Tanuj Bhartiya, Shibal Vanathi, Murugesan Panda, Anita |
author_sort | Dada, Tanuj |
collection | PubMed |
description | Glaucoma drainage devices are an option in refractory glaucomas for control of intraocular pressure (IOP). We evaluated the outcome of pars plana Ahmed glaucoma valve along with triamcinolone-assisted vitrectomy in 11 eyes with uncontrolled IOP on maximum tolerable antiglaucoma therapy. The mean preoperative IOP of 33.64 ± 5.99 (range 26 to 44 mmHg) decreased to 17.09 ± 2.26 (range 14 to 20 mmHg) and 17.45 ± 1.81mm of Hg (range 14 to 24 mmHg) at 6 and 12 months following surgery. The mean number of antiglaucoma medications decreased from 3.27 ± 0.05 to 0.64 ± 0.67 and 0.55 ± 0.6 at 6 and 12 months following surgery. |
format | Text |
id | pubmed-2992926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-29929262010-12-14 Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas Dada, Tanuj Bhartiya, Shibal Vanathi, Murugesan Panda, Anita Indian J Ophthalmol Brief Communications Glaucoma drainage devices are an option in refractory glaucomas for control of intraocular pressure (IOP). We evaluated the outcome of pars plana Ahmed glaucoma valve along with triamcinolone-assisted vitrectomy in 11 eyes with uncontrolled IOP on maximum tolerable antiglaucoma therapy. The mean preoperative IOP of 33.64 ± 5.99 (range 26 to 44 mmHg) decreased to 17.09 ± 2.26 (range 14 to 20 mmHg) and 17.45 ± 1.81mm of Hg (range 14 to 24 mmHg) at 6 and 12 months following surgery. The mean number of antiglaucoma medications decreased from 3.27 ± 0.05 to 0.64 ± 0.67 and 0.55 ± 0.6 at 6 and 12 months following surgery. Medknow Publications 2010 /pmc/articles/PMC2992926/ /pubmed/20689206 http://dx.doi.org/10.4103/0301-4738.67068 Text en © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Communications Dada, Tanuj Bhartiya, Shibal Vanathi, Murugesan Panda, Anita Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas |
title | Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas |
title_full | Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas |
title_fullStr | Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas |
title_full_unstemmed | Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas |
title_short | Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas |
title_sort | pars plana ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas |
topic | Brief Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992926/ https://www.ncbi.nlm.nih.gov/pubmed/20689206 http://dx.doi.org/10.4103/0301-4738.67068 |
work_keys_str_mv | AT dadatanuj parsplanaahmedglaucomavalveimplantationwithtriamcinoloneassistedvitrectomyinrefractoryglaucomas AT bhartiyashibal parsplanaahmedglaucomavalveimplantationwithtriamcinoloneassistedvitrectomyinrefractoryglaucomas AT vanathimurugesan parsplanaahmedglaucomavalveimplantationwithtriamcinoloneassistedvitrectomyinrefractoryglaucomas AT pandaanita parsplanaahmedglaucomavalveimplantationwithtriamcinoloneassistedvitrectomyinrefractoryglaucomas |